Abstract | OBJECTIVE: METHODS: Twenty-four patients with myeloid leukemia underwent allogeneic bone marrow transplantation. The donors of twelve patients (study group) were given G-CSF 250 microg/d for seven days prior to harvesting. The marrow cell composition, the outcome of subsequent engraftment and the occurrence of aGVHD were compared with those in twelve patients without G-CSF (control group). RESULTS: The bone marrow stimulated by G-CSF yielded higher number of nucleated cells, CD34+ cells, CFU-GM and CFU-MK (P < 0.01). The number of T lymphocyte subsets in the graft stimulated with G-CSF was different from that in the control group. The number of CD4+ cells was decreased and that of CD8+ increased. The CD4+/CD8+ ratio was reduced markedly (P < 0.01). The change of CD34+, CD4+, CD8+ percentage and CFU-GM, CFU-MK proliferation in donor bone marrow with and without G-CSF was compared. The same characteristic change as above graft was observed. Hemopoietic reconstitution in the study group after allo-BMT was accelerated. In the study group the days of granulocyte count exceeding 0.5 x 10(9)/L and platelet count exceeding 20 x 10(9)/L were 16 days (range 11 - 23 days) and 17 days (range 14 - 25 days) (in the control group 20.5 day, range 14 - 29 days and 23 days, range 17 - 32 days P < 0.05). Grade II - IV aGVHD did not occur in patients of the study group but in 3 patients of the control group. CONCLUSION: The bone marrow harvested from donor with G-CSF stimulation can accelerate hemopoietic recovery and decrease the incidence of severe aGVHD. The accelerated hematopoietic recovery is associated with increased number of CD34+, CFU-GM and CFU-MK in the graft.
|
Authors | S Ji, H Chen, H Wang, H Yan, S Pan |
Journal | Zhonghua nei ke za zhi
(Zhonghua Nei Ke Za Zhi)
Vol. 40
Issue 12
Pg. 834-7
(Dec 2001)
ISSN: 0578-1426 [Print] China |
PMID | 16206675
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Granulocyte Colony-Stimulating Factor
|
Topics |
- Adolescent
- Adult
- Bone Marrow Cells
(drug effects, immunology)
- Bone Marrow Transplantation
- Female
- Graft vs Host Disease
(prevention & control)
- Granulocyte Colony-Stimulating Factor
(administration & dosage, pharmacology)
- Hematopoietic Stem Cell Mobilization
(methods)
- Humans
- Leukemia
(therapy)
- Male
- Tissue Donors
- Transplantation, Homologous
- Treatment Outcome
|